Production (Stage)
Firefly Neuroscience, Inc.
AIFF
$3.46
$0.102.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -18.87% | 60.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.87% | 60.61% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -18.87% | 60.61% | |||
| SG&A Expenses | -17.54% | -36.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.39% | -39.20% | |||
| Operating Income | 19.40% | 39.97% | |||
| Income Before Tax | -241.79% | 11.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -241.61% | 11.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -241.61% | 11.75% | |||
| EBIT | 19.40% | 39.97% | |||
| EBITDA | 20.02% | 40.01% | |||
| EPS Basic | -300.44% | 28.20% | |||
| Normalized Basic EPS | -290.19% | 45.06% | |||
| EPS Diluted | -300.44% | 28.20% | |||
| Normalized Diluted EPS | -290.19% | 45.06% | |||
| Average Basic Shares Outstanding | 14.41% | 22.91% | |||
| Average Diluted Shares Outstanding | 14.41% | 22.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||